Thymosin Fraction 5 Boosted Immune Cell Receptor Expression in Human Cells
Thymosin peptides increased IL-2 receptor density on human immune cells, enhancing their ability to respond to growth signals.
Quick Facts
What This Study Found
Thymosin fraction 5 (TF5), a mix of thymic peptides, significantly increased both the percentage of human lymphocytes expressing IL-2 receptors (IL-2R) and the density of receptors on each cell. This happened after the cells were stimulated with PHA (a plant protein that activates immune cells).
Synthetic thymosin alpha 1 alone produced the same effect, identifying it as the active ingredient in TF5.
The effect was direct. When researchers used cyclosporin A (a drug that blocks IL-2 production), TF5 still increased IL-2R expression. This means thymosin works by directly putting more receptors on cells, not by making more IL-2. More receptors led to stronger cell multiplication.
Key Numbers
How They Did This
In vitro study using human blood lymphocytes. Cells were stimulated with PHA or OKT3 monoclonal antibody. IL-2 receptor expression was measured by flow cytometry. Thymosin fraction 5 and synthetic thymosin alpha 1 were tested. Cyclosporin A was used to confirm the effect was independent of IL-2 production.
Why This Research Matters
IL-2 receptors are the gatekeepers of immune cell multiplication. Without enough receptors, immune cells cannot respond to growth signals. This study showed thymosin alpha 1 directly upregulates these receptors, explaining how it boosts immunity. This mechanism is relevant to AIDS (where IL-2R expression is low) and aging.
The Bigger Picture
IL-2 receptors are the switches that allow immune cells to multiply and fight threats. By increasing receptor expression, thymosin peptides amplify the immune response at a fundamental level.
What This Study Doesn't Tell Us
In vitro study using cells from presumably healthy donors. The effect in cells from immunocompromised patients may differ. The study did not test whether this receptor increase translates to better immune function in living people.
Questions This Raises
- ?Could this receptor upregulation enhance cancer immunotherapy?
- ?Does thymosin increase IL-2R in immunocompromised patients?
Trust & Context
- Key Stat:
- Increased IL-2 receptor density Both number of cells and receptors per cell increased
- Evidence Grade:
- Moderate in-vitro evidence using human cells with flow cytometry — rigorous methodology for the era.
- Study Age:
- Published in 1986 — key mechanistic finding explaining how thymosin boosts immune function.
- Original Title:
- Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.
- Published In:
- Proceedings of the National Academy of Sciences of the United States of America, 83(16), 6107-11 (1986)
- Authors:
- Sztein, M B(4), Serrate, S A(3), Goldstein, A L(11)
- Database ID:
- RPEP-00037
Evidence Hierarchy
Frequently Asked Questions
What are IL-2 receptors?
IL-2 receptors are protein switches on immune cells that detect interleukin-2, a growth signal. When activated, they trigger immune cells to multiply and become more aggressive against threats.
Why does receptor density matter?
More receptors per cell means the cell is more sensitive to activation signals. A cell with double the receptors responds to lower levels of IL-2, making the immune response more efficient.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00037APA
Sztein, M B; Serrate, S A; Goldstein, A L. (1986). Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.. Proceedings of the National Academy of Sciences of the United States of America, 83(16), 6107-11.
MLA
Sztein, M B, et al. "Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.." Proceedings of the National Academy of Sciences of the United States of America, 1986.
RethinkPeptides
RethinkPeptides Research Database. "Modulation of interleukin 2 receptor expression on normal hu..." RPEP-00037. Retrieved from https://rethinkpeptides.com/research/sztein-1986-modulation-of-interleukin-2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.